Silvio Inzucchi

Silvio Inzucchi, MD, is Professor of Medicine (Endocrinology) at Yale University School of Medicine, where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship. He is a leading expert in diabetes management, with a focus on pharmacological therapies and cardiovascular outcomes.

Education:

• BS, Fordham University (1981)
• MD, Harvard Medical School (1985)
• Residency, Internal Medicine, Yale-New Haven Hospital
• Fellowship, Endocrinology and Metabolism, Yale-New Haven Hospital

Dr. Inzucchi’s research centers on clinical diabetes management, particularly pharmacological antihyperglycemic therapy and the cardiovascular complications of type 2 diabetes and insulin resistance. His work bridges clinical practice and large-scale trials, aiming to improve patient outcomes through evidence-based strategies. He has been instrumental in shaping national and international guidelines, including co-chairing the 2012 and 2015 ADA-EASD Position Statements on Hyperglycemia in Type 2 Diabetes.

His recent publications reflect a strong trend in cardiovascular and renal outcomes of diabetes medications, especially SGLT2 inhibitors and GLP-1 receptor agonists. These studies, published in top journals like Circulation, JAMA Cardiology, and Diabetes Care, often involve meta-analyses of major trials such as SOUL, DAPA-HF, and DELIVER, highlighting the real-world impact of these therapies on heart failure, kidney function, and quality of life.

Scientific Awards and Recognition:

• David J. Leffell Prize for Clinical Excellence, Yale University
• Named 'Top Doctor' by local and national rankings

Dr. Inzucchi is actively involved in clinical mentoring and education as Fellowship Program Director and through his academic clinical practice. He has led and participated in numerous federally and industry-funded clinical trials, contributing to the advancement of diabetes therapeutics. His work is supported by affiliations with the Yale Diabetes Center, Diabetes Research Center, and Yale Center for Clinical Investigation (YCCI).

He is a frequent national and international speaker on diabetes management and has served on editorial boards for Diabetes Care and the Journal of Clinical Endocrinology and Metabolism.